[go: up one dir, main page]

YU43010B - Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones - Google Patents

Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones

Info

Publication number
YU43010B
YU43010B YU810/81A YU81081A YU43010B YU 43010 B YU43010 B YU 43010B YU 810/81 A YU810/81 A YU 810/81A YU 81081 A YU81081 A YU 81081A YU 43010 B YU43010 B YU 43010B
Authority
YU
Yugoslavia
Prior art keywords
piperidinylalkyl
pyrido
pyrimidine
ones
obtaining new
Prior art date
Application number
YU810/81A
Other languages
English (en)
Other versions
YU81081A (en
Inventor
L E Kennis
J C Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU81081A publication Critical patent/YU81081A/xx
Publication of YU43010B publication Critical patent/YU43010B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU810/81A 1980-03-28 1981-03-27 Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones YU43010B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (2)

Publication Number Publication Date
YU81081A YU81081A (en) 1983-12-31
YU43010B true YU43010B (en) 1989-02-28

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
YU810/81A YU43010B (en) 1980-03-28 1981-03-27 Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones

Country Status (22)

Country Link
US (1) US4342870A (xx)
EP (1) EP0037265B1 (xx)
AU (1) AU537700B2 (xx)
BG (1) BG36199A3 (xx)
CA (1) CA1163994A (xx)
CS (1) CS256366B2 (xx)
DE (1) DE3168433D1 (xx)
DK (1) DK159390C (xx)
ES (1) ES8300763A1 (xx)
FI (1) FI71737C (xx)
GR (1) GR72488B (xx)
HU (1) HU187329B (xx)
IE (1) IE51319B1 (xx)
IL (1) IL62494A (xx)
MA (1) MA19107A1 (xx)
NO (1) NO156752C (xx)
NZ (1) NZ196522A (xx)
PH (1) PH16530A (xx)
PT (1) PT72740B (xx)
RO (1) RO82508A (xx)
SU (1) SU1068037A3 (xx)
YU (1) YU43010B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ATE146077T1 (de) * 1986-09-22 1996-12-15 Janssen Pharmaceutica Nv Serotonin-antagonisten zur behandlung von wunden
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
WO1990011093A1 (en) * 1989-03-23 1990-10-04 Mallinckrodt, Inc. Radioactive iodine- or bromine labelled piperidine compound as well as method of preparing same and composition comprising said compound
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
JP3357879B2 (ja) * 1992-02-13 2002-12-16 メレルダウファーマス−ティカルズ インコーポレイテッド ピペリジニルチア環状誘導体類
CA2137673C (en) 1992-07-13 2005-09-06 Jan Vandenberk Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
DK0729357T3 (da) * 1993-11-19 2005-06-06 Janssen Pharmaceutica Nv Mikroindkapslede 1,2-benzazoler
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
AU2003288017A1 (en) * 2002-11-13 2004-06-03 Synthon B.V. Process for making risperidone and intermediates therefor
EP1615924A1 (en) * 2003-04-22 2006-01-18 Synthon B.V. Water soluble salts of risperidone
CN101970427A (zh) * 2008-02-29 2011-02-09 Vm生物医药公司 治疗疼痛症状及其它失调的方法
CN108299314B (zh) * 2012-02-10 2024-11-26 Ptc医疗公司 用于治疗脊髓性肌萎缩的化合物
EP2819519B1 (en) 2012-03-01 2019-10-23 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
BR112014023483B1 (pt) 2012-03-23 2022-05-10 Ptc Therapeutics, Inc Composto e seu uso, composição farmacêutica e seu uso
EP2970188A4 (en) * 2013-03-15 2016-10-19 Vm Therapeutics Llc NOVEL CRYSTALLINE FORMS
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
LT3386511T (lt) 2015-12-10 2021-08-25 Ptc Therapeutics, Inc. Hantingtono ligos gydymo būdai
CN110352007A (zh) 2016-11-28 2019-10-18 Ptc医疗公司 用于调节rna剪接的方法
IL300875A (en) 2017-06-05 2023-04-01 Ptc Therapeutics Inc Compounds for the treatment of Huntington's disease
CN111372611A (zh) 2017-06-14 2020-07-03 Ptc医疗公司 修饰rna剪接的方法
CA3067591A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
KR20210005559A (ko) 2018-03-27 2021-01-14 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
RS65727B1 (sr) 2018-06-27 2024-08-30 Ptc Therapeutics Inc Heterociklična i heteroaril jedinjenja za lečenje hantingtonove bolesti
CN112805280B (zh) 2018-06-27 2024-12-06 Ptc医疗公司 用于治疗亨廷顿氏病的杂芳基化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
SU1068037A3 (ru) 1984-01-15
EP0037265B1 (en) 1985-01-23
PH16530A (en) 1983-11-10
NO811058L (no) 1981-09-29
CA1163994A (en) 1984-03-20
EP0037265A1 (en) 1981-10-07
DK159390B (da) 1990-10-08
AU6842981A (en) 1981-10-01
RO82508A (ro) 1983-09-26
NZ196522A (en) 1985-10-11
YU81081A (en) 1983-12-31
IL62494A (en) 1984-08-31
ES500814A0 (es) 1982-11-01
NO156752B (no) 1987-08-10
RO82508B (ro) 1983-08-30
GR72488B (xx) 1983-11-14
PT72740A (en) 1981-04-01
BG36199A3 (en) 1984-09-14
FI71737B (fi) 1986-10-31
MA19107A1 (fr) 1981-10-01
PT72740B (en) 1982-11-16
CS256366B2 (en) 1988-04-15
NO156752C (no) 1987-11-18
HU187329B (en) 1985-12-28
DK138281A (da) 1981-09-29
IL62494A0 (en) 1981-05-20
FI71737C (fi) 1987-02-09
FI810956L (fi) 1981-09-29
IE51319B1 (en) 1986-12-10
DK159390C (da) 1991-03-04
AU537700B2 (en) 1984-07-05
IE810706L (en) 1981-09-28
ES8300763A1 (es) 1982-11-01
US4342870A (en) 1982-08-03
DE3168433D1 (de) 1985-03-07

Similar Documents

Publication Publication Date Title
YU43010B (en) Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones
RO83101B (ro) Procedeu de preparare a unor derivati de nicotinamida
HUT34741A (en) Process for preparing new derivatives of 1-ethyl-2,6-dimethyl-8-hydroxy-polyhydro-naphthalene
YU126281A (en) Process for obtaining new pyridoxine derivatives
PL232331A1 (en) Method of obtaining new derivatives of 6a,10 n-trans-9-beta-amino-1-hydroxyocta-hydrobenzene/o/ quinoline
PT73712A (en) Process for the production of derivatives of 2-(2-benzofuranyl)ethanolamine
YU42448B (en) Process for obtaining derivative of 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)pyridinone-2-
PL232330A1 (en) Method of obtaining new derivatives of oxazolidinodione-2,4
GR64892B (en) Method for the preparation of new derivatives of 1,3 diphenoxypropan-2-on
PL241179A1 (en) Process for preparing novel derivatives of 4a,9b-trans-hexahydro-1h-pyridoindole
YU44524B (en) Process for obtaining derivatives of 3,4-dihydro-2h-benzopyrans
PT72565A (en) Process for the preparation of phenoxy-aminopropanol derivatives
AU9141182A (en) 9-(3-(3,5-cis-dimethylpiperazino)propyl)carbazole for treatment of anxiety
YU81181A (en) Process for obtaining substituted derivatives
PL235949A1 (en) Process for preparing derivatives of 2,3,4-trinor-1,5-inter-m-phenyleneprostacyclin
NZ197563A (en) 3-(1,2,4-triazinylthiomethyl)-3-cephem-1-sulphoxide derivatives
YU163779A (en) Process for obtaining imidazolyl-ethoxy derivatives of pyrrazolo (3,4-b)-pyridine-5-methanol
YU295080A (en) Process for obtaining new derivatives of 1-xo-1h-thiazolo (3,2-a)pyrimidine-2-carboxamides
HU182341B (en) Process for preparing new substituted phenoxy-amino-propanol derivatives
PH19848A (en) Process for the preparation of 5,6,7,7a-tetrahydro-4-thieno (3,2-c)-pyridin-2-one derivatives
PT73870A (en) Process for the preparation of 11-dodecen-1-yl derivatives
PT74114B (en) Process for the preparation of 1,2-dihydro-5-(pyridinyl)-nico- tinamide derivatives
YU250379A (en) Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5-diphenyl-oxazole
DE3163891D1 (en) Process for the preparation of vinylphosphoric-acid derivatives
PL231451A1 (en) Process for preparing derivatives of methylquinoxaline 1,4-dioxide